UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 193

Sortiert nach

Strontium Ranelate Reduces the Risk of Nonvertebral Fractures in Postmenopausal Women with Osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) Study

The journal of clinical endocrinology and metabolism, 2005-05, Vol.90 (5), p.2816-2822

2005

Volltextzugriff (PDF)

Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2013-10, Vol.382 (9902), p.1424-1432

2013

Volltextzugriff (PDF)

Treatment of bone diseases with bisphosphonates, excluding osteoporosis

Current opinion in rheumatology, 2000-07, Vol.12 (4), p.331-335

Devogelaer, Jean-Pierre

2000

Volltextzugriff (PDF)

Treatment of osteoporosis in men

Bone (New York, N.Y.), 2013-03, Vol.53 (1), p.134-144

2013

Volltextzugriff (PDF)

Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of Osteoarthritis

Drugs & aging, 2015-03, Vol.32 (3), p.179-187

2015

Volltextzugriff (PDF)

Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications

Osteoporosis international, 2012-02, Vol.23 (Suppl 1), p.1-23

2012

Volltextzugriff (PDF)

Intravenous Zoledronic Acid in Postmenopausal Women with Low Bone Mineral Density

The New England journal of medicine, 2002-02, Vol.346 (9), p.653-661

2002

Volltextzugriff (PDF)

Efficacy and Safety of Daily Risedronate in the Treatment of Corticosteroid‐Induced Osteoporosis in Men and Women: A Randomized Trial

Journal of bone and mineral research, 2000-06, Vol.15 (6), p.1006-1013

2000

Volltextzugriff (PDF)

The Effects of Strontium Ranelate on the Risk of Vertebral Fracture in Women with Postmenopausal Osteoporosis

The New England journal of medicine, 2004-01, Vol.350 (5), p.459-468

2004

Volltextzugriff (PDF)

Recommendations for the registration of drugs used in the treatment of osteoarthritis

Annals of the rheumatic diseases, 1996-08, Vol.55 (8), p.552-557

1996

Volltextzugriff (PDF)

Deflazacort in giant cell arteritis

Journal of rheumatology, 2002-10, Vol.29 (10), p.2244

2002

Volltextzugriff (PDF)

Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis : a consensus document of the Belgian Bone Club

Osteoporosis international, 2006-01, Vol.17 (1), p.8-19

2006

Volltextzugriff (PDF)

Effects of Calcitonin on Subchondral Trabecular Bone Changes and on Osteoarthritic Cartilage Lesions After Acute Anterior Cruciate Ligament Deficiency

Journal of bone and mineral research, 2004-11, Vol.19 (11), p.1821-1826

2004

Volltextzugriff (PDF)

Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2001-03, Vol.285 (11), p.1482

2001

Volltextzugriff (PDF)

Safety and Efficacy of a Novel Salmon Calcitonin (sCT) Technology‐Based Oral Formulation in Healthy Postmenopausal Women: Acute and 3‐Month Effects on Biomarkers of Bone Turnover

Journal of bone and mineral research, 2004-09, Vol.19 (9), p.1531-1538

2004

Volltextzugriff (PDF)

Dietary Chicory Inulin Increases Whole-Body Bone Mineral Density in Growing Male Rats

The Journal of nutrition, 2002-12, Vol.132 (12), p.3599-3602

2002

Volltextzugriff (PDF)

Remission Over 3 Years in Patients with Paget Disease of Bone Treated with a Single Intravenous Infusion of 5 mg Zoledronic Acid

Calcified tissue international, 2014-03, Vol.94 (3), p.311-318

2014

Volltextzugriff (PDF)

A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study

Rheumatology (Oxford, England), 2005-04, Vol.44 (4), p.465-468

2005

Volltextzugriff (PDF)

Inhomogeneity of human vertebral cancellous bone: systematic density and structure patterns inside the vertebral body

Bone (New York, N.Y.), 2001-05, Vol.28 (5), p.563-571

2001

Volltextzugriff (PDF)

Beneficial effects of creatine supplementation in dystrophic patients

Muscle & nerve, 2003-05, Vol.27 (5), p.604-610

2003

Volltextzugriff (PDF)

Guidelines for clinical studies assessing the efficacy of drugs for the management of acute low back pain

Clinical and experimental rheumatology, 2003-11, Vol.21 (6), p.691

2003

Volltextzugriff (PDF)

Inulin and fructo-oligosaccharides differ in their ability to enhance the density of cancellous and cortical bone in the axial and peripheral skeleton of growing rats

Bone (New York, N.Y.), 2006-03, Vol.38 (3), p.394-399

2006

Volltextzugriff (PDF)

Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy

Calcified tissue international, 2001-10, Vol.69 (4), p.242-247

2001

Volltextzugriff (PDF)

Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone Club

Osteoporosis international, 2005-03, Vol.16 (3), p.239-254

2005

Volltextzugriff (PDF)

Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis

Osteoarthritis and cartilage, 2004-04, Vol.12 (4), p.263-268

2004

Volltextzugriff (PDF)

1 – 25 von 193

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(173)
Mit Volltextzugriff
(153)

Publikationsform

Artikel
(168)
Webseiten
(25)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Strontium Ranelate Reduces the Risk of Nonvertebral Fractures in Postmenopausal Women with Osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) Study

Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial

Treatment of bone diseases with bisphosphonates, excluding osteoporosis

Treatment of osteoporosis in men

Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of Osteoarthritis

Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications

Intravenous Zoledronic Acid in Postmenopausal Women with Low Bone Mineral Density

Efficacy and Safety of Daily Risedronate in the Treatment of Corticosteroid‐Induced Osteoporosis in Men and Women: A Randomized Trial

The Effects of Strontium Ranelate on the Risk of Vertebral Fracture in Women with Postmenopausal Osteoporosis

Recommendations for the registration of drugs used in the treatment of osteoarthritis

Deflazacort in giant cell arteritis

Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis : a consensus document of the Belgian Bone Club

Effects of Calcitonin on Subchondral Trabecular Bone Changes and on Osteoarthritic Cartilage Lesions After Acute Anterior Cruciate Ligament Deficiency

Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial

Safety and Efficacy of a Novel Salmon Calcitonin (sCT) Technology‐Based Oral Formulation in Healthy Postmenopausal Women: Acute and 3‐Month Effects on Biomarkers of Bone Turnover

Dietary Chicory Inulin Increases Whole-Body Bone Mineral Density in Growing Male Rats

Remission Over 3 Years in Patients with Paget Disease of Bone Treated with a Single Intravenous Infusion of 5 mg Zoledronic Acid

A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study

Inhomogeneity of human vertebral cancellous bone: systematic density and structure patterns inside the vertebral body

Beneficial effects of creatine supplementation in dystrophic patients

Guidelines for clinical studies assessing the efficacy of drugs for the management of acute low back pain

Inulin and fructo-oligosaccharides differ in their ability to enhance the density of cancellous and cortical bone in the axial and peripheral skeleton of growing rats

Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy

Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone Club

Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis

Suchergebnisse filtern